Participating in a stem cell or bone marrow transplant clinical trial means access to lifesaving new treatment. Learn more and see what trials are underway.

Our stem cell and bone marrow transplant program has high success rates for children coping with serious illnesses. Thanks to recent innovations, we can offer many children a cure for blood cancers and nonmalignant blood disorders. These advances are made possible, in part, by clinical trials of new treatments.

At Johns Hopkins All Children’s Cancer & Blood Disorders Institute in St. Petersburg, Florida, our patients can participate in numerous clinical trials. These trials give your child access to leading-edge therapies close to home.

• As a member of Johns Hopkins Medicine, which is based in Baltimore, we can offer patients greater access to early (Phase 1 and 2) clinical trials. Our patients can take part in any trial ongoing at Johns Hopkins, without leaving Florida’s west coast.
• We also collaborate with the Moffitt Cancer Center, Children’s Oncology Group, Pediatric Blood and Marrow Transplant Consortium and other pediatric hospitals. By working with other cancer centers, our trials have larger study groups, leading to better outcomes.

What Is a Clinical Trial?

Researchers evaluate treatments and medications through clinical trials. Patients are monitored closely to determine the most effective stem cell and bone marrow transplant approaches.

A clinical trial outlines a specific treatment plan. Each clinical trial has a protocol (set of rules) that explains how it will work. The protocol must be approved by the organization sponsoring the study.

Stem cell and bone marrow transplant (BMT) clinical trials are important for testing treatments and determining if BMT is the most effective therapy for various conditions.